ProfileGDS4718 / 207582_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 61% 65% 63% 67% 58% 62% 66% 64% 62% 66% 60% 64% 63% 60% 62% 62% 60% 62% 62% 61% 65% 59% 60% 66% 61% 61% 64% 59% 61% 65% 64% 60% 67% 61% 60% 61% 62% 64% 66% 61% 62% 64% 59% 58% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.1800261
GSM549102patient 115, normal, homogenized [OPG study]6.4625965
GSM549104patient 119, normal, homogenized [OPG study]6.3327563
GSM549108patient 138, normal, homogenized [OPG study]6.6458467
GSM549119patient 077, normal, homogenized [OPG study]6.0185658
GSM549133patient 032, cancer, homogenized [OPG study]6.2651962
GSM549139patient 042, cancer, homogenized [OPG study]6.5648866
GSM549099patient 107, normal, homogenized [OPG study]6.3852464
GSM549109patient 139, normal, homogenized [OPG study]6.2388962
GSM549110patient 046, normal, homogenized [OPG study]6.5304566
GSM549114patient 063, normal, homogenized [OPG study]6.0695760
GSM549122patient 082, normal, homogenized [OPG study]6.4073964
GSM549134patient 033, cancer, homogenized [OPG study]6.335463
GSM549136patient 036, cancer, homogenized [OPG study]6.0897960
GSM549140patient 044, cancer, homogenized [OPG study]6.2920862
GSM549111patient 047, normal, homogenized [OPG study]6.2878562
GSM549113patient 057, normal, homogenized [OPG study]6.0721860
GSM549132patient 031, cancer, homogenized [OPG study]6.2481562
GSM549137patient 038, cancer, homogenized [OPG study]6.2884662
GSM549142patient 047, cancer, homogenized [OPG study]6.2999461
GSM549100patient 110, normal, homogenized [OPG study]6.4511765
GSM549107patient 135, normal, homogenized [OPG study]6.0490159
GSM549115patient 068, normal, homogenized [OPG study]6.0779360
GSM549116patient 072, normal, homogenized [OPG study]6.5276266
GSM549120patient 078, normal, homogenized [OPG study]6.1651461
GSM549131patient 030, cancer, homogenized [OPG study]6.2030361
GSM549118patient 074, normal, homogenized [OPG study]6.4047264
GSM549129patient 027, cancer, homogenized [OPG study]6.0678459
GSM549123patient 088, normal, homogenized [OPG study]6.2117261
GSM549124patient 006, cancer, homogenized [OPG study]6.4408365
GSM549126patient 015, cancer, homogenized [OPG study]6.4253264
GSM549128patient 025, cancer, homogenized [OPG study]6.1211260
GSM549103patient 117, normal, homogenized [OPG study]6.6228767
GSM549117patient 073, normal, homogenized [OPG study]6.1487461
GSM549138patient 041, cancer, homogenized [OPG study]6.1449560
GSM549141patient 045, cancer, homogenized [OPG study]6.198361
GSM549130patient 028, cancer, homogenized [OPG study]6.277662
GSM549101patient 111, normal, homogenized [OPG study]6.4456264
GSM549105patient 128, normal, homogenized [OPG study]6.5239966
GSM549106patient 134, normal, homogenized [OPG study]6.1633361
GSM549112patient 048, normal, homogenized [OPG study]6.2842662
GSM549125patient 011, cancer, homogenized [OPG study]6.3625164
GSM549127patient 024, cancer, homogenized [OPG study]6.0760959
GSM549135patient 035, cancer, homogenized [OPG study]5.974558